Stocks
Zynerba Pharmaceuticals (ZYNE) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.48 | 2.04 | 1.13 | 1.86 | 1.45 | 0.93 | |||
| Changes by years, y/y, % | -22% | +38% | -44% | +64% | -22% | -5.3% | |||
Zynerba Pharmaceuticals. Debt/EBITDA
Zynerba Pharmaceuticals. Debt/EBITDA, changes, %
Zynerba Pharmaceuticals (ZYNE) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2022Q2 | FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | LTM ? | |||
| Debt/EBITDA | 1.68 | 1.60 | 1.46 | 1.23 | 0.94 | 0.93 | ||
| Changes by years, y/y, % | -27% | -19% | -21% | -34% | -44% | |||
| Changes by quarters, q/q, % | -9% | -5% | -8% | -16% | -23% | |||
